Home › Funds › NAN FUNG TRINITY (HK) Ltd › ZLAB
NAN FUNG TRINITY (HK) Ltd position in ZLAB
ZAI LAB LTD · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 293,966 shares of ZLAB (ZAI LAB LTD) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 0.74% of its reported portfolio and ranking #46 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed ZLAB holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's ZLAB position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in ZLAB in Q2 2025 at 269,975 shares (US$9.4M). Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 293,966 shares valued at US$7.7M — a reduction of -52,500 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 269.98K | $9.44M | New |
| Q3 2025 | 269.98K | $9.15M | Hold |
| Q4 2025 | 269.98K | $4.76M | Hold |
| Q1 2026 | 346.47K | $6.52M | Add |
| Q2 2026 | 346.47K | $6.58M | Hold |
| Q3 2026 | 293.97K | $7.74M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZLAB and 13F data
ZLAB (ZAI LAB LTD) is a Health Care company. 16 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZLAB
- RTW INVESTMENTS, LP 6.57M sh · $124.91M · Q2 2026
- TCG Crossover Management, LLC 6.14M sh · $116.61M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 5.74M sh · $109.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.37M sh · $64.01M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.90M sh · $36.14M · Q2 2026
- Patient Square Capital LP 591.51K sh · $15.58M · Q3 2026
- Rock Springs Capital Management LP 814.71K sh · $15.48M · Q2 2026
- C WorldWide Group Holding A/S 510.00K sh · $13.43M · Q3 2026
- B Group, Inc. 450.65K sh · $8.56M · Q2 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held ZLAB?
NAN FUNG TRINITY (HK) Ltd has disclosed ZLAB holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in ZLAB?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 293.97K shares of ZLAB (ZAI LAB LTD), valued at $7.74M, representing 0.74% of its reported portfolio and ranking #46.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling ZLAB?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd reduced its position in ZLAB.
Which other funds hold ZLAB?
Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 16 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.